Skip to main content

Table 2 Antimicrobial Susceptibility pattern of Enterobacteriaceae isolates among HIV infected children at the University of Gondar Comprehensive Specialized Hospital, 2020

From: Fecal carriage of extended spectrum beta-lactamase producing Enterobacteriaceae among HIV infected children at the University of Gondar Comprehensive Specialized Hospital Gondar, Ethiopia

Name of antibiotics

Antimicrobial resistance pattern of each species of Enterobacteriacae

E. coli (N = 111)

K.pneumoniae (N = 30)

K.ozenia (N = 4)

Proteus species (N = 4)

Providencia species (N = 3)

Citrobacter species (N = 9)

Eenterobacter species (N = 12)

Salmonella species (N = 7)

Shigella species (N = 6)

Row total N (%)

AMP

S

3 (2.7)

1 (3.3)

2 (50)

   

2 (16.7)

  

8 (4.3)

I

13 (11.7)

2 (6.7)

   

2 (22.2)

  

3 (50)

20 (10.8)

R

95 (85.6)

27 (90)

2 (50)

4 (100)

3 (100)

7 (77.8)

10 (83.3)

7 (100)

3 (50)

158 (85)

AMX

S

1 (0.9)

1 (3.3)

2 (50)

  

1 (11.1)

1 (8.3)

  

6 (3.2)

I

3 (2.7)

        

3 (1.6)

R

107 (96.4)

29 (96.7)

2 (50)

4 (100)

3 (100)

8 (88.9)

11 (91.7)

7 (100)

6 (100)

177 (95.1)

AMC

S

41 (36.9)

11 (36.7)

2 (50)

1 (25)

2 (66.7)

2 (22.2)

5 (41.7)

2 (28.6)

3 (50)

68 (36.6)

I

17 (15.3)

8 (26.7)

1 (25)

  

2 (22.2)

 

1 (14.3)

1 (16.7)

30 (16.1)

R

53 (47.7)

11 (36.7)

1 (25)

3 (75)

1 (33.3)

5 (55.6)

7 (58.3)

4 (57.1)

2 (33.3)

87 (46.8)

CTX

S

97 (87.4)

26 (86.7)

4 (100)

4 (100)

2 (66.7)

8 (88.9)

8 (66.7)

6 (85.7)

6 (100)

161 (86.6)

I

3 (2.7)

   

1 (33.3)

 

1 (8.3)

  

5 (2.7)

R

11 (9.9)

4 (13.3)

   

1 (11.1)

3 (25)

1 (14.3)

 

20 (10.8)

CAZ

S

100 (90)

28 (93.3)

4 (100)

4 (100)

3 (100)

8 (88.9)

12 (100)

6 (85.7)

6 (100)

(91.9)

I

2 (1.8)

        

2 (1.1)

R

9 (8.1)

2 (6.7)

   

1 (11.1)

 

1 (14.3)

 

13 (7)

CXM

S

99 (89.2)

27 (90)

4 (100)

4 (100)

3 (100)

6 (66.7)

9 (75)

7 (100)

6 (100)

165 (88.7)

I

4 (3.6)

        

4 (2.2)

R

8 (7.2)

3 (10)

   

3 (33.3)

3 (25)

  

17 (9.1)

CXT

S

108 (97.3)

25 (83.3)

4 (100)

3 (75)

3 (100)

6 (66.7)

10 (83.3)

7 (100)

5 (83.3)

171 (91.9)

I

1 (0.9)

2 (6.7)

    

1 (8.3)

 

1 (16.7)

5 (2.7)

R

2 (1.8)

3 (10)

 

1 (25)

 

3 (33.3)

1 (8.3)

  

10 (5.4)

CIP

S

82 (73.9)

22 (73.3)

 

2 (50)

 

7 (77.8)

11 (91.7)

5 (71.4)

4 (66.7)

133 (71.5)

I

22 (19.8)

7 (23.3)

4 (100)

1 (25)

3 (100)

2 (22.2)

 

2 (28.6)

2 (33.3)

43 (23.1)

R

7 (6.3)

1 (3.3)

 

1 (25)

  

1 (8.3)

  

10 (5.4)

SXT

S

63 (56.8)

17 (56.7)

2 (50)

1 (25)

1 (33.3)

4 (44.4)

7 (58.3)

1 (14.3)

4 (66.7)

100 (53.8)

I

3 (2.7)

 

1 (25)

   

1 (8.3)

  

5 (2.7)

R

45 (40.5)

13 (43.3)

1 (25)

3 (75)

2 (66.7)

5 (55.6)

4 (33.3)

6 (85.7)

2 (33.3)

81 (43.5)

CHL

S

103 (92.8)

28 (93.3)

4 (100)

4 (100)

3 (100)

8 (88.9)

12 (100)

7 (100)

6 (100)

175 (94.1)

R

8 (7.2)

2 (1.8)

   

1 (11.1)

   

11 (5.9)

TET

S

52 (46.8)

15 (50)

3 (75)

1 (25)

3 (100)

6 (66.7)

7 (58.3)

2 (28.6)

2 (33.3)

88 (47.3)

I

6 (5.4)

1 (3.3)

      

1 (16.7)

8 (4.3)

R

53 (47.7)

14 (46.7)

1 (25)

3 (75)

 

3 (33.3)

5 (41.7)

5 (71.4)

3 (50)

87 (46.8)

  1. AMP: ampicillin: AMX: amoxicillin; AMC: amoxicillin-clavulanic acid; CTX: cefotaxime; CAZ: ceftazidime; CXM: cefixime; CXT: cefoxitine; CIP: ciprofloxacin; SXT: Trimethoprim-Sulfamethoxazole; CHL: chloramphenicol; TET: tetracycline
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us